Inflammation and Immunity in Cancer

Inbunden, Engelska, 2015

Av Tsukasa Seya, Misako Matsumoto, Keiko Udaka, Noriyuki Sato

1 429 kr

Beställningsvara. Skickas inom 10-15 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

This book overviews cancer immunity from broad scientific fields, based on the concept that cancer is a sort of by-product of infection, inflammation, and host immune response.

Produktinformation

Utgivningsdatum2015-04-08
Mått155 x 235 x 17 mm
Vikt544 g
FormatInbunden
SpråkEngelska
Antal sidor268
Upplaga2015
FörlagSpringer Verlag, Japan
ISBN9784431553267

Tillhör följande kategorier

Onkologi inom Medicin

Preface.- 1 Role of bone marrow-derived CCR1+ cells in colon cancer invasion and metastasis.- 2 PGE2-associated inflammation and gastrointestinal tumorigenesis.- 3 Regulation of tumor-associated myeloid cells by innate immune signaling.- 4 The role of PIKfyve in TLR-mediated inflammation and immune responses.- 5 Emerging roles of an innate immune regulator TAPE in the Toll-like receptor and RIG-I-like receptor pathways.- 6 Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like phenotypes in adult T-cell leukemia/lymphoma cells.- 7 Tumor-associated molecular patterns: its implication in tumoricidal inflammation.- 8 Host factors involved in the propagation and pathogenesis of hepatitis C virus.- 9 HCV-induced inflammation: The role of cross-talk between HCV-infected hepatocytes and stellate cells.- 10 Development of immunotherapy for hepatocellular carcinoma.- 11 Development of glypican-3-targeted cancer immunotherapy.- 12 The vesicular traffic system in plasmacytoid dendritic cells as a target for immune regulation.- 13 In vivo targeting of dendritic cells with artificial adjuvant vector cells (aAVC) as a novel cancer immunotherapy.- 14 Enhancement of efficacy of WT1 peptide cancer vaccine by co-administration with immunopotentiating agents: Lessons from mouse models.- 15 Regulation of antigen-presentation by dendritic cells and its application to cancer immunotherapy.- 16 A new mode of CTL induction secondary to alteration of pMHCI repertoire by antigen processing defects.- 17 Progress in clinical use of CCR4 antibody for regulatory T cell suppression.- 18 Adjuvant Immunotherapy for cancer: Basic research to clinical bench.- 19 Immunological regulation of human cancer stem cell/cancer-initiating cells (CSC/CIC).- 20 Overview on tumor immunology.-BM Epilogue.